Does estrogen stimulate osteoblast function in postmenopausal women?

Abstract:

:How estrogen therapy influences bone metabolism in postmenopausal women has previously been studied using several approaches, including bone densitometry, measurement of biochemical markers of bone turnover, and histomorphometry. Taken together, these investigations suggest that conventional doses of estrogen protect from bone loss predominantly through suppression of bone resorption, with little evidence to suggest that a stimulatory action on osteoblasts is also involved. In contrast, studies of patients treated with estradiol implants suggest that, following prolonged exposure to relatively high estrogen levels, an additional stimulatory effect on osteoblast function is observed. The suggestion that estrogen stimulates osteoblast activity in postmenopausal women under certain circumstances is consistent with other evidence that estrogen is an important physiological regulator of osteoblast activity. Furthermore, these findings raise the possibility that it may be useful to develop strategies for treating postmenopausal osteoporosis that aim to reproduce the stimulatory action of relatively high estrogen levels on bone formation in postmenopausal women.

journal_name

Bone

journal_title

Bone

authors

Tobias JH,Compston JE

doi

10.1016/s8756-3282(98)00156-2

subject

Has Abstract

pub_date

1999-02-01 00:00:00

pages

121-4

issue

2

eissn

8756-3282

issn

1873-2763

pii

S8756-3282(98)00156-2

journal_volume

24

pub_type

杂志文章,评审

相关文献

BONE文献大全
  • Platelets can neutralize hydrogen peroxide in an acute toxicity model with cells involved in granulation tissue formation.

    abstract::Platelets play a key role in the replacement of the blood clot with granulation tissue during the early steps of bone regeneration. We hypothesized that activated platelets can neutralize locally produced reactive oxygen species, thereby protecting cells involved in granulation tissue formation. The potential of plate...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.01.015

    authors: Kandler B,Maitz P,Fischer MB,Watzek G,Gruber R

    更新日期:2005-04-01 00:00:00

  • Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment.

    abstract::Cortical bone, the dominant component of the human skeleton by volume, plays a key role in protecting bones from fracture. We analyzed the cortical bone effects of teriparatide treatment in postmenopausal women with osteoporosis who had previously received long-term alendronate (ALN) therapy or were treatment naïve (T...

    journal_title:Bone

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.bone.2013.11.011

    authors: Ma YL,Zeng QQ,Chiang AY,Burr D,Li J,Dobnig H,Fahrleitner-Pammer A,Michalská D,Marin F,Pavo I,Stepan JJ

    更新日期:2014-02-01 00:00:00

  • A review on computer modeling of bone piezoelectricity and its application to bone adaptation and regeneration.

    abstract::Bone is a hierarchical, multiphasic and anisotropic structure which in addition possess piezoelectric properties. The generation of piezoelectricity in bone is a complex process which has been shown to play a key role both in bone adaptation and regeneration. In order to understand the complex biological, mechanical a...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2019.07.024

    authors: Mohammadkhah M,Marinkovic D,Zehn M,Checa S

    更新日期:2019-10-01 00:00:00

  • Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium.

    abstract::Mutations in the GALNT3 gene result in familial tumoral calcinosis, characterized by persistent hyperphosphatemia and ectopic calcific masses in soft tissues. Since calcific masses often recur after surgical removal, a more permanent solution to the problem is required. Nicotinamide is reported to lower serum phosphat...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.06.036

    authors: Reilly AM,Gray AK,Moe SM,Ichikawa S

    更新日期:2014-10-01 00:00:00

  • Objectively measured physical activity is associated with parameters of bone in 70-year-old men and women.

    abstract::As the world's population ages, the occurrence of osteoporosis-related fractures is projected to increase. Low areal bone mineral density (aBMD), a well-known risk factor for fractures, may be influenced by physical activity (PA). In this cross-sectional study, we aimed to investigate potential associations between ob...

    journal_title:Bone

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.bone.2015.07.001

    authors: Johansson J,Nordström A,Nordström P

    更新日期:2015-12-01 00:00:00

  • Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD).

    abstract:INTRODUCTION:The GH-IGF axis has profound effects on bone metabolism and may be important in the etiology of idiopathic osteoporosis. Serum IGF-I is often low in men with osteoporosis, which may be attributable to GH hypo-secretion or hepatic GH insensitivity. We studied the GH-IGF axis in depth to look for evidence to...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.06.016

    authors: Patel MB,Arden NK,Masterson LM,Phillips DI,Swaminathan R,Syddall HE,Byrne CD,Wood PJ,Cooper C,Holt RI,Hertfordshire Cohort Study Group.

    更新日期:2005-12-01 00:00:00

  • 1Alpha,25-dihydroxy-2beta(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus remodeling but did not interfere with fracture healing in rat femora.

    abstract:INTRODUCTION:Because osteoporotic patients are prone to fractures, it must be considered whether or not patients undergoing drug therapies should discontinue treatment after sustaining a non-vertebral fracture. This study has tested the effect of novel active vitamin D3 analog, 1alpha,25-dihydroxy-2beta(3-hydroxypropox...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2006.07.023

    authors: Cao Y,Mori S,Mashiba T,Kaji Y,Manabe T,Iwata K,Miyamoto K,Komatsubara S,Yamamoto T

    更新日期:2007-01-01 00:00:00

  • Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.

    abstract::Eldecalcitol (ELD), a 2β-hydroxypropyloxy derivative of 1α,25 (OH) 2D3, inhibits bone resorption more potently than alfacalcidol (ALF) while maintaining osteoblastic function in an ovariectomized (OVX) osteoporosis rat model. Alendronate (ALN), which is the most common bisphosphonate used for the treatment of osteopor...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.09.031

    authors: Sugimoto M,Futaki N,Harada M,Kaku S

    更新日期:2013-01-01 00:00:00

  • Mineralization pathways in the active murine epiphyseal growth plate.

    abstract::Endochondral ossification in the growth plate of long bones involves cartilage mineralization, bone formation and the budding vasculature. Many of these processes take place in a complex and dynamic zone, the provisional ossification zone, of the growth plate. Here we investigate aspects of mineralization in 2D and 3D...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.115086

    authors: Haimov H,Shimoni E,Brumfeld V,Shemesh M,Varsano N,Addadi L,Weiner S

    更新日期:2020-01-01 00:00:00

  • The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption.

    abstract::Osteoclasts are specialized secretory cells of the myeloid lineage important for normal skeletal homeostasis as well as pathologic conditions of bone including osteoporosis, inflammatory arthritis and cancer metastasis. Differentiation of these multinucleated giant cells from precursors is controlled by the cytokine R...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.08.113

    authors: Charles JF,Coury F,Sulyanto R,Sitara D,Wu J,Brady N,Tsang K,Sigrist K,Tollefsen DM,He L,Storm D,Aliprantis AO

    更新日期:2012-11-01 00:00:00

  • The type II collagen N-propeptide, PIIBNP, inhibits cell survival and bone resorption of osteoclasts via integrin-mediated signaling.

    abstract:OBJECTIVE:Type IIB procollagen is characteristic of cartilage, comprising 50% of the extracellular matrix. The NH(2)-propeptide of type IIB collagen, PIIBNP, can kill tumor cells via binding to integrins α(V)β(3) and α(V)β(5). As osteoclasts rely on α(V)β(3) integrins for function in bone erosion, we sought to determin...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.06.011

    authors: Hayashi S,Wang Z,Bryan J,Kobayashi C,Faccio R,Sandell LJ

    更新日期:2011-10-01 00:00:00

  • Proteomic studies of bone and skeletal health outcomes.

    abstract::Proteins are an essential part of essentially all biological processes, and there is enormous variation in protein forms and concentrations that is not reflected in DNA or RNA. Recently there have been rapid advances in the ability to measure protein sequence, modification and concentration, particularly with methods ...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2019.03.032

    authors: Nielson CM,Jacobs JM,Orwoll ES

    更新日期:2019-09-01 00:00:00

  • Subregional areal bone mineral density (aBMD) is a better predictor of heterogeneity in trabecular microstructure of vertebrae in young and aged women than subregional trabecular bone score (TBS).

    abstract:BACKGROUND:Currently, bone densitometry fails to identify nearly half of those elderly patients at immediate fracture risk. To improve clinical assessment of vertebral fracture risk, we aimed to determine how the DXA-based 2D parameter Trabecular Bone Score (TBS) relates to subregional variability in 3D trabecular micr...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.02.014

    authors: Vom Scheidt A,Grisolia Seifert EF,Pokrant C,Püschel K,Amling M,Busse B,Milovanovic P

    更新日期:2019-05-01 00:00:00

  • Repair of a segmental long bone defect in human by implantation of a novel multiple disc graft.

    abstract::Large segmental defects of the weight bearing long bones are very difficult to reconstruct. Current treatment options are afflicted with several limitations and disadvantages. We describe a novel approach to regenerate a segmental long bone defect in a patient using a multiple disc graft. Decellularized bovine trabecu...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.02.011

    authors: Hesse E,Kluge G,Atfi A,Correa D,Haasper C,Berding G,Shin HO,Viering J,Länger F,Vogt PM,Krettek C,Jagodzinski M

    更新日期:2010-05-01 00:00:00

  • Circulating sclerostin is elevated in short-term and reduced in long-term SCI.

    abstract::Spinal cord injury (SCI) causes profound bone loss due to muscle paralysis resulting in the inability to walk. Sclerostin, a Wnt signaling pathway antagonist produced by osteocytes, is a potent inhibitor of bone formation. Short-term studies in rodent models have demonstrated increased sclerostin in response to mechan...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.04.019

    authors: Battaglino RA,Sudhakar S,Lazzari AA,Garshick E,Zafonte R,Morse LR

    更新日期:2012-09-01 00:00:00

  • Unsaturation level decreased in bone marrow fat of postmenopausal women with low bone density using high resolution magic angle spinning (HRMAS) 1H NMR spectroscopy.

    abstract::There are increasing evidences suggesting bone marrow adiposity tissue (MAT) plays a critical role in affecting both bone quantity and quality. However, very limited studies that have investigated the association between the composition of MAT and bone mineral density (BMD). The goal of this study was to quantify MAT ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2017.08.014

    authors: Li X,Shet K,Xu K,Rodríguez JP,Pino AM,Kurhanewicz J,Schwartz A,Rosen CJ

    更新日期:2017-12-01 00:00:00

  • Differences in the microarchitectural features of the lateral collapsed lesion between osteonecrosis and subchondral insufficiency fracture of the femoral head.

    abstract:BACKGROUND:Like osteonecrosis of the femoral head (ONFH), subchondral insufficiency fracture of the femoral head (SIF) causes femoral head collapse. However, little is known about the differences between the two diseases regarding the morphological features of the collapsed lesion. We tested the hypothesis that the mor...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115585

    authors: Kawano K,Motomura G,Ikemura S,Yamaguchi R,Baba S,Xu M,Nakashima Y

    更新日期:2020-12-01 00:00:00

  • Histomorphometric analysis of the effects of osteocyte density on osteonal morphology and remodeling.

    abstract::Osteocytes, the most abundant cells in the cortical bone matrix, are thought to have mechanosensory and chemosensory regulatory roles. Marotti theorized that osteocytes signal to osteoblasts to recruit them into the osteocyte lineage. Martin extended this theory, assuming that osteocytes display a general inhibitory e...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(03)00245-x

    authors: Metz LN,Martin RB,Turner AS

    更新日期:2003-11-01 00:00:00

  • Vector-averaged gravity-induced changes in cell signaling and vitamin D receptor activity in MG-63 cells are reversed by a 1,25-(OH)2D3 analog, EB1089.

    abstract::Skeletal unloading in an animal hindlimb suspension model and microgravity experienced by astronauts or as a result of prolonged bed rest causes site-specific losses in bone mineral density of 1%-2% per month. This is accompanied by reductions in circulating levels of 1,25-(OH)(2)D(3), the active metabolite of vitamin...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(02)00836-0

    authors: Narayanan R,Smith CL,Weigel NL

    更新日期:2002-09-01 00:00:00

  • Casein kinase 2 regulates in vivo bone formation through its interaction with bone morphogenetic protein receptor type Ia.

    abstract::Approximately 7.9 million fractures occur annually in the United States with 5-10% of these resulting in delayed or impaired healing. Nearly half of the trauma cost of $56 billion per year is used for the treatment of fractures. More importantly, fracture results in a substantial reduction in the quality of life. New ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.06.037

    authors: Bragdon B,Thinakaran S,Moseychuk O,Gurski L,Bonor J,Price C,Wang L,Beamer WG,Nohe A

    更新日期:2011-11-01 00:00:00

  • Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats.

    abstract::The skeletal consequences of streptozotocin-induced (STZ) diabetes in the rat are characterized by decreased bone formation and, consequently, reductions in bone mass. Given the ability of tetracyclines to inhibit the breakdown of connective tissue collagen in experimental diabetes (and in other diseases), we examined...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(97)00104-x

    authors: Bain S,Ramamurthy NS,Impeduglia T,Scolman S,Golub LM,Rubin C

    更新日期:1997-08-01 00:00:00

  • Characterization of the effect of chronic administration of a calcium-sensing receptor antagonist, ronacaleret, on renal calcium excretion and serum calcium in postmenopausal women.

    abstract::Ronacaleret is an orally-active calcium-sensing receptor (CaSR) antagonist that has the potential for therapeutic utility in the stimulation of PTH release, notably as a bone anabolic agent comparable to recombinant human PTH(1-34) (rhPTH(1-34)). A recent study has shown that, despite the ability to increase circulati...

    journal_title:Bone

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.bone.2013.05.021

    authors: Caltabiano S,Dollery CT,Hossain M,Kurtinecz MT,Desjardins JP,Favus MJ,Kumar R,Fitzpatrick LA

    更新日期:2013-09-01 00:00:00

  • Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application.

    abstract::Many clinical and experimental investigations address the influence of statins on bone formation and fracture healing. Simvastatin was shown to increase the expression of Bone morphogenetic protein (BMP-2), which is one of the most potent growth factors targeting bone formation. In this study, the effect of simvastati...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2009.05.010

    authors: Pauly S,Luttosch F,Morawski M,Haas NP,Schmidmaier G,Wildemann B

    更新日期:2009-09-01 00:00:00

  • Safety of bisphosphonates.

    abstract::Bisphosphonates are one of the most well studied groups of medications and they are bone specific. This tissue specificity is a rare property for a drug introduced into clinical practice as long as 40 years ago. Over the years, the therapeutic boundaries of bisphosphonates were explored and their safety profile has wi...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2011.01.003

    authors: Pazianas M,Abrahamsen B

    更新日期:2011-07-01 00:00:00

  • Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506.

    abstract::Immunosuppressant drugs are currently required by transplant recipients for the remainder of their lives, despite the many adverse effects associated with these therapies. Acute osteoporosis is one such effect, and a reproducible osteoporosis model has been established through the administration of the immunosuppressa...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2003.05.003

    authors: Fukunaga J,Yamaai T,Yamachika E,Ishiwari Y,Tsujigiwa H,Sawaki K,Lee YJ,Ueno T,Kirino S,Mizukawa N,Takagi S,Nagai N,Sugahara T

    更新日期:2004-03-01 00:00:00

  • An in vivo genome wide gene expression study of circulating monocytes suggested GBP1, STAT1 and CXCL10 as novel risk genes for the differentiation of peak bone mass.

    abstract::Peak bone mass (PBM) is an important determinant of osteoporosis. Circulating monocytes serve as early progenitors of osteoclasts and produce important molecules for bone metabolism. To search for genes functionally important for PBM variation, we performed a whole genome gene differential expression study of circulat...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.05.016

    authors: Lei SF,Wu S,Li LM,Deng FY,Xiao SM,Jiang C,Chen Y,Jiang H,Yang F,Tan LJ,Sun X,Zhu XZ,Liu MY,Liu YZ,Chen XD,Deng HW

    更新日期:2009-05-01 00:00:00

  • Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible.

    abstract::The cathepsin K (CatK) inhibitor odanacatib (ODN) is currently being developed for the treatment of osteoporosis. In clinical trials, efficacy and resolution of effect of ODN treatment on bone turnover biomarkers and accrued bone mass have been demonstrated. Here, we examine the effects of continuing treatment and dis...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2014.07.013

    authors: Zhuo Y,Gauthier JY,Black WC,Percival MD,Duong LT

    更新日期:2014-10-01 00:00:00

  • Sclerostin deficiency in humans.

    abstract::Sclerosteosis and van Buchem disease are two rare bone sclerosing dysplasias caused by genetic defects in the synthesis of sclerostin. In this article we review the demographic, clinical, biochemical, radiological, and histological characteristics of patients with sclerosteosis and van Buchem disease that led to a bet...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2016.10.010

    authors: van Lierop AH,Appelman-Dijkstra NM,Papapoulos SE

    更新日期:2017-03-01 00:00:00

  • Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis.

    abstract::Mammalian bone sialoprotein (BSP) is a mineralized tissue-specific protein containing an RGD (arginine-glycine-aspartic acid) cell-attachment sequence and two distinct glutamic acid (glu)-rich regions, with each containing one contiguous glu sequence. These regions have been proposed to contribute to the attachment of...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(00)00392-6

    authors: Harris NL,Rattray KR,Tye CE,Underhill TM,Somerman MJ,D'Errico JA,Chambers AF,Hunter GK,Goldberg HA

    更新日期:2000-12-01 00:00:00

  • Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.

    abstract::Alendronate has been shown to reduce bone turnover and increase bone mass. However, little is known about the duration of the effect on bone after treatment withdrawal. The aim of this study was to investigate the long-term effects on bone mineral density (BMD) and bone turnover of various alendronate regimens after t...

    journal_title:Bone

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s8756-3282(03)00112-1

    authors: Bagger YZ,Tankó LB,Alexandersen P,Ravn P,Christiansen C

    更新日期:2003-09-01 00:00:00